دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
دانلود کتاب Bradley and Daroffs Neurology in Clinical Practice
دانلود کتاب عصب شناسی بردلی و داروفس در عمل بالینی
مشخصات کتاب
Bradley and Daroffs Neurology in Clinical Practice
ویرایش: [8 ed.] نویسندگان: Joseph Jankovic, John C. Mazziottam, Scott L. Pomeroy, Nancy J. Newman سری: ISBN (شابک) : 9780323642613 ناشر: Elsevier سال نشر: 2022 تعداد صفحات: [3078] زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 114 Mb
قیمت کتاب (تومان) : 57,000
در صورت تبدیل فایل کتاب Bradley and Daroffs Neurology in Clinical Practice به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب عصب شناسی بردلی و داروفس در عمل بالینی نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
توضیحاتی درمورد کتاب به خارجی
فهرست مطالب
01 02 03 Bradley and Daroff's Neurology in Clinical Practice (8th Edition)-2022.pdf (p.1-2875) i - 0 ii - 1 ii - 2 ii - Dedication Dedication iii Volume I - Front Matter of Volume I BRADLEY and DAROFF’S NEUROLOGY in Clinical Practice iii Volume II - Front Matter of Volume II BRADLEY and DAROFF’S NEUROLOGY in Clinical Practice iv - Copyright copyright v - content id=b1slEAAAQBAJ&pg=RA1-PR5&img=1&zoom=3&hl=en&sig=ACfU3U1TOIwnV id=b1slEAAAQBAJ&pg=RA1-PR6&img=1&zoom=3&hl=en&sig=ACfU3U2Ci7wv1 id=b1slEAAAQBAJ&pg=RA1-PR7&img=1&zoom=3&hl=en&sig=ACfU3U2NgFZJX viii - Preface PREFACE x - List of Contributors LIST OF CONTRIBUTORS xx - 1 - 1 - Diagnosis of Neurological Disease 1 - Diagnosis of Neurological Disease 8 - 2 – Episodic Impairment of Consciousness 2 - Episodic Impairment of Consciousness SYNCOPE History and Physical Examination Causes of Syncope Investigations of Patients with Syncope SEIZURES Pathophysiology History and Physical Examination SEIZURE CLASSIFICATION Absence Seizures Tonic-Clonic Seizures Complex Partial Seizures Investigations of Seizures Psychogenic Nonepileptic Spells MISCELLANEOUS CAUSES OF ALTERED CONSCIOUSNESS REFERENCES 17 - 3 - Falls and Drop Attacks 3 - Falls and Drop Attacks FALLS AND DROP ATTACKS—INTRODUCTION 23 - 4 - Delirium 4 - Delirium CLINICAL CHARACTERISTICS 34 - 5 - Stupor and Coma 52 - 6 - Prolonged Comatose States and Brain Death 58 - 7 - Intellectual and Memory Impairments 67 - 8 - Global Developmental Delay and Regression 8 - Global Developmental Delay and Regression TYPICAL AND ATYPICAL DEVELOPMENT 75 - 9 - Behavior and Personality Disturbances 9 - Behavior and Personality Disturbances 97 - 10 - Depression and Psychosis in Neurological Practice 10 - Depression and Psychosis in Neurological Practice PRINCIPLES OF DIFFERENTIAL DIAGNOSIS 120 - 11 - Limb Apraxias and Related Disorders 127 - 12 - Agnosias 12 - Agnosias VISUAL AGNOSIAS 133 - 13 - Aphasia and Aphasic Syndromes 13 - Aphasia and Aphasic Syndromes 149 - 14 - Dysarthria and Apraxia of Speech 14 - Dysarthria and Apraxia of Speech MOTOR SPEECH DISORDERS 152 - 15 - Neurogenic Dysphagia 164 - 16 - Neuro-Ophthalmology_ Afferent Visual System 191 - 17 - Pupillary and Eyelid Abnormalities 17 - Pupillary and Eyelid Abnormalities PUPILLARY ABNORMALITIES 201 - 18 - Neuro-ophthalmology_ Ocular Motor System 18 - Neuro-ophthalmology: Ocular Motor System GENERAL PRINCIPLES OF OCULAR MOTOR CONTROL EYE MOVEMENT ANATOMY 241 - 19 - Disturbances of Smell and Taste 19 - Disturbances of Smell and Taste ANATOMY AND PHYSIOLOGY 248 - 20 - Cranial and Facial Pain 255 - 21 - Brainstem Syndromes 21 - Brainstem Syndromes OCULAR MOTOR SYNDROMES 267 - 22 - Neuro-Otology_ Diagnosis and Management of Neuro-Otological Disorders 22 - Neuro-Otology: Diagnosis and Management of Neuro-Otological Disorders HISTORICAL BACKGROUND 288 - 23 - Cerebellar Ataxia 23 - Cerebellar Ataxia 310 - 24 - Diagnosis and Assessment of Parkinson Disease and Other Movement Disorders 24 - Diagnosis and Assessment of Parkinson Disease and Other Movement Disorders 334 - 25 - Gait Disorders 25 - Gait Disorders 345 - 26 – Hemiplegia and Monoplegia 26 - Hemiplegia and Monoplegia ANATOMY AND PHYSIOLOGY 356 - 27 - Paraplegia and Spinal Cord Syndromes 27 - Paraplegia and Spinal Cord Syndromes 362 - 28 - Proximal, Distal, and Generalized Weakness 28 - Proximal, Distal, and Generalized Weakness 379 - 29 - Muscle Pain and Cramps 29 - Muscle Pain and Cramps 388 - 30 - Hypotonic (Floppy) Infant 30 - Hypotonic (Floppy) Infant 397 - 31 - Sensory Abnormalities of the Limbs, Trunk, and Face 31 - Sensory Abnormalities of the Limbs, Trunk, and Face ANATOMY AND PHYSIOLOGY 407 - 32 - Arm and Neck Pain 32 - Arm and Neck Pain CLINICAL ASSESSMENT 417 - 33 - Lower Back and Lower Limb Pain 33 - Lower Back and Lower Limb Pain ANATOMY AND PHYSIOLOGY APPROACH TO DIAGNOSIS OF LOW BACK AND LEG PAIN 427 - Investigations in the Diagnosis and Management of Neurological Disease 34 - Investigations in the Diagnosis and Management of Neurological Disease DIAGNOSTIC YIELD OF ANCILLARY TESTS INTERPRETATION OF RESULTS OF INVESTIGATIONS RELIABILITY OF INVESTIGATIONS DECISION ANALYSIS RESEARCH INVESTIGATIONS AND TEACHING HOSPITALS PATIENT CONFIDENTIALITY 430 - 35 - Electroencephalography and Evoked Potentials 35 - Electroencephalography and Evoked Potentials 447 - 36 - Clinical Electromyography 36 - Clinical Electromyography NERVE CONDUCTION STUDIES 472 - 37 - Extracranial Neuromodulation 37 - Extracranial Neuromodulation 483 - 38 - Intracranial Neuromodulation 38 - Intracranial Neuromodulation 492 - 39 - Intraoperative Monitoring 39 - Intraoperative Monitoring 496 - 40 - Structural Imaging Using Magnetic Resonance Imaging and Computed Tomography 40 - Structural Imaging Using Magnetic Resonance Imaging and Computed Tomography 547 - 41 - Vascular Imaging_ Computed Tomographic Angiography, Magnetic Resonance Angiography, and Ultrasound 41 - Vascular Imaging: Computed Tomographic Angiography, Magnetic Resonance Angiography, and Ultrasound COMPUTED TOMOGRAPHIC ANGIOGRAPHY 576 - 42 - Functional and Molecular Neuroimaging 42 - Functional and Molecular Neuroimaging 601 - 43 - Ocular Functional and Structural Investigations 43 - Ocular Functional and Structural Investigations 614 - 44 - Neuropsychology 44 - Neuropsychology 633 - 45 - Neurourology 45 - Neurourology 652 - 46 - Sexual Dysfunction in Neurological Disorders 46 - Sexual Dysfunction in Neurological Disorders 666 - 47 - Neuroepidemiology 47 - Neuroepidemiology 681 - 48 - Clinical Neurogenetics 48 - Clinical Neurogenetics GENETICS IN CLINICAL NEUROLOGY 709 - 49 - Neuroimmunology 49 - Neuroimmunology IMMUNE SYSTEM 730 - 50 - Neuroendocrinology 50 - Neuroendocrinology 748 - 51 - Management of Neurological Disease 51 - Management of Neurological Disease 753 - 52 - Pain Management 52 - Pain Management DEFINITION AND CHALLENGE 776 - 53 - Neurointensive Care 53 - Neurointensive Care 793 - 54 - Principles of Neuroendovascular Therapy 54 - Principles of Neuroendovascular Therapy 819 - 55 - Neurological Rehabilitation B - Neurological Complications of Systemic Disease 55 - Neurological Rehabilitation 850 - 56 - Transition to Adult Care for Youth with Chronic Neurological Disorders 856 - 57 - Palliative and End-of-Life Care in Neurological Disease 57 - Palliative and End-of-Life Care in Neurological Disease 862 - 58 - Neurological Complications of Systemic Disease_ Adults_ 58 - Neurological Complications of Systemic Disease: Adults* 882 - 59 - Neurological Complications of Systemic Disease_ Children 59 - Neurological Complications of Systemic Disease: Children 897 - 60 - Basic Neuroscience of Neurotrauma 60 - Basic Neuroscience of Neurotrauma 907 - 61 - Concussion in Sports and Performance 61 - Concussion in Sports and Performance 914 - 62 – Craniocerebral Trauma 62 - Craniocerebral Trauma 929 - 63 - Spinal Cord Trauma 63 - Spinal Cord Trauma EPIDEMIOLOGY 950 - 64 - Trauma of the Nervous System_ Peripheral Nerve Trauma 64 - Trauma of the Nervous System: Peripheral Nerve Trauma 964 - 65 - Ischemic Cerebrovascular Disease 65 - Ischemic Cerebrovascular Disease 1014 - 66 - Intracerebral Hemorrhage 66 - Intracerebral Hemorrhage 1031 - 67 - Intracranial Aneurysms and Subarachnoid Hemorrhage 67 - Intracranial Aneurysms and Subarachnoid Hemorrhage EPIDEMIOLOGY 1044 - 68 - Stroke in Children 68 - Stroke in Children 1058 - 69 - Spinal Cord Vascular Disease 69 - Spinal Cord Vascular Disease 1066 - 70 - Central Nervous System Vasculitis 70 - Central Nervous System Vasculitis 1068 - 71 - Epidemiology of Brain Tumors 71 - Epidemiology of Brain Tumors 1076 - 72 - Pathology and Molecular Genetics 72 - Pathology and Molecular Genetics 1099 - 73 - Clinical Features of Brain Tumors and Complications of Their Treatment 73 - Clinical Features of Brain Tumors and Complications of Their Treatment 1105 - 74 - Primary Nervous System Tumors in Adults 74 - Primary Nervous System Tumors in Adults GENERAL ASPECTS 1122 - 75 - Primary Nervous System Tumors in Infants and Children 75 - Primary Nervous System Tumors in Infants and Children 1145 - 76 - Nervous System Metastases 76 - Nervous System Metastases BRAIN METASTASES 1165 - 77 - Neurological Manifestations of Human Immunodeficiency Virus Infection in Adults 77 - Neurological Manifestations of Human Immunodeficiency Virus Infection in Adults EPIDEMIOLOGY AND CURRENT TRENDS 1184 - 78 - Viral Encephalitis and Meningitis 78 - Viral Encephalitis and Meningitis 1214 - 79 - Bacterial, Fungal, and Parasitic Diseases of the Nervous System 79 - Bacterial, Fungal, and Parasitic Diseases of the Nervous System 1226 - 80 - Multiple Sclerosis and Other Inflammatory Demyelinating Diseases of the Central Nervous System 80 - Multiple Sclerosis and Other Inflammatory Demyelinating Diseases of the Central Nervous System 1255 - 81 - Paraneoplastic Disorders of the Nervous System 81 - Paraneoplastic Disorders of the Nervous System 1263 - 82 - Autoimmune Encephalitis with Antibodies to Cell Surface Antigens 82 - Autoimmune Encephalitis with Antibodies to Cell Surface Antigens 1269 - 83 - Anoxic-Ischemic Encephalopathy 83 - Anoxic-Ischemic Encephalopathy PATHOPHYSIOLOGICAL CONCEPTS 1276 - 84 - Toxic and Metabolic Encephalopathies 84 - Toxic and Metabolic Encephalopathies 1291 - 85 - Deficiency Diseases of the Nervous System 85 - Deficiency Diseases of the Nervous System COBALAMIN (VITAMIN B12) 1302 - 86 - Effects of Toxins and Physical Agents on the Nervous System 86 - Effects of Toxins and Physical Agents on the Nervous System 1319 - 87 - Effects of Drug Abuse on the Nervous System 87 - Effects of Drug Abuse on the Nervous System DRUGS OF DEPENDENCE 1327 - 88 - Brain Edema and Disorders of Cerebrospinal Fluid Circulation 88 - Brain Edema and Disorders of Cerebrospinal Fluid Circulation 1345 - 89 - Developmental Disorders of the Nervous System 89 - Developmental Disorders of the Nervous System 1366 - 90 - Autism and Other Neurodevelopmental Disabilities 90 - Autism and Other Neurodevelopmental Disabilities 1386 - 91 - Inborn Errors of Metabolism and the Nervous System 91 - Inborn Errors of Metabolism and the Nervous System 1407 - 92 - Neurodegenerative Disease Processes 92 - Neurodegenerative Disease Processes WHERE DO NEURODEGENERATIVE DISORDERS BEGIN? 1415 - 93 - Mitochondrial Disorders 93 - Mitochondrial Disorders 1430 - 94 - Prion Diseases 94 - Prion Diseases 1452 - 95 - Alzheimer Disease and Other Dementias 95 - Alzheimer Disease and Other Dementias 1498 - 96 - Parkinson Disease and Other Movement Disorders 96 - Parkinson Disease and Other Movement Disorders 1535 - 97 - Disorders of Upper and Lower Motor Neurons 97 - Disorders of Upper and Lower Motor Neurons 1568 - 98 - Channelopathies_ Episodic and Electrical Disorders of the Nervous System 98 - Channelopathies: Episodic and Electrical Disorders of the Nervous System 1589 - 99 – Neurocutaneous Syndromes 99 - Neurocutaneous Syndromes 1614 - 100 – Epilepsies 100 - Epilepsies 1664 - 101 - Sleep and Its Disorders 101- Sleep and Its Disorders 1745 - 102 - Headache and Other Craniofacial Pain 102 - Headache and Other Craniofacial Pain PAIN TRANSMISSION AND MODULATION AS RELATED TO HEADACHE 1783 - 103 - Cranial Neuropathies 103 - Cranial Neuropathies OLFACTORY NERVE (CRANIAL NERVE I) 1798 - 104 - Disorders of Bones, Joints, Ligaments, and Meninges 104 - Disorders of Bones, Joints, Ligaments, and Meninges 1829 - 105 - Disorders of Nerve Roots and Plexuses 105 - Disorders of Nerve Roots and Plexuses DISORDERS OF NERVE ROOTS 1853 - 106 - Disorders of Peripheral Nerves 106 - Disorders of Peripheral Nerves CLINICAL APPROACH TO DISORDERS OF PERIPHERAL NERVES 1930 - 107 - Disorders of the Autonomic Nervous System 107 - Disorders of the Autonomic Nervous System 1958 - 108 - Disorders of Neuromuscular Transmission 108 - Disorders of Neuromuscular Transmission 1978 - 109 - Disorders of Skeletal Muscle 109 - Disorders of Skeletal Muscle 2022 - 110 – Neurological Problems in the Newborn 110 - Neurological Problems in the Newborn 2040 - 111 - Cerebral Palsy 111 - Cerebral Palsy 2049 - 112 - Neurological Problems of Pregnancy 112 - Neurological Problems of Pregnancy NEUROLOGICAL COMPLICATIONS OF CONTRACEPTION 2076 - 113 - Functional and Dissociative Neurological Symptoms and Disorders 113 - Functional and Dissociative Neurological Symptoms and Disorders 2093 - index Index M id=b1slEAAAQBAJ&pg=RA2-PA101&img=1&zoom=3&hl=en&sig=ACfU3U1RYwg id=b1slEAAAQBAJ&pg=RA2-PA102&img=1&zoom=3&hl=en&sig=ACfU3U1mpHZ id=b1slEAAAQBAJ&pg=RA2-PA103&img=1&zoom=3&hl=en&sig=ACfU3U0w7TO id=b1slEAAAQBAJ&pg=RA2-PA104&img=1&zoom=3&hl=en&sig=ACfU3U2vTLC id=b1slEAAAQBAJ&pg=RA2-PA105&img=1&zoom=3&hl=en&sig=ACfU3U1XLr6 id=b1slEAAAQBAJ&pg=RA2-PA106&img=1&zoom=3&hl=en&sig=ACfU3U03niJ id=b1slEAAAQBAJ&pg=RA2-PA107&img=1&zoom=3&hl=en&sig=ACfU3U2_b4M id=b1slEAAAQBAJ&pg=RA2-PA108&img=1&zoom=3&hl=en&sig=ACfU3U2L1tN id=b1slEAAAQBAJ&pg=RA2-PA109&img=1&zoom=3&hl=en&sig=ACfU3U0m-XR id=b1slEAAAQBAJ&pg=RA2-PA110&img=1&zoom=3&hl=en&sig=ACfU3U232j8 id=b1slEAAAQBAJ&pg=RA2-PA111&img=1&zoom=3&hl=en&sig=ACfU3U1_TCg id=b1slEAAAQBAJ&pg=RA2-PA112&img=1&zoom=3&hl=en&sig=ACfU3U3e0yB id=b1slEAAAQBAJ&pg=RA2-PA113&img=1&zoom=3&hl=en&sig=ACfU3U3QqZc id=b1slEAAAQBAJ&pg=RA2-PA114&img=1&zoom=3&hl=en&sig=ACfU3U059db id=b1slEAAAQBAJ&pg=RA2-PA115&img=1&zoom=3&hl=en&sig=ACfU3U024iz id=b1slEAAAQBAJ&pg=RA2-PA116&img=1&zoom=3&hl=en&sig=ACfU3U3_6cb id=b1slEAAAQBAJ&pg=RA2-PA117&img=1&zoom=3&hl=en&sig=ACfU3U354qs id=b1slEAAAQBAJ&pg=RA2-PA118&img=1&zoom=3&hl=en&sig=ACfU3U3F5da id=b1slEAAAQBAJ&pg=RA2-PA119&img=1&zoom=3&hl=en&sig=ACfU3U1gWX1 id=b1slEAAAQBAJ&pg=RA2-PA120&img=1&zoom=3&hl=en&sig=ACfU3U32Bx8 id=b1slEAAAQBAJ&pg=RA2-PA121&img=1&zoom=3&hl=en&sig=ACfU3U0Ke-5 id=b1slEAAAQBAJ&pg=RA2-PA122&img=1&zoom=3&hl=en&sig=ACfU3U0zraB id=b1slEAAAQBAJ&pg=RA2-PA123&img=1&zoom=3&hl=en&sig=ACfU3U1xKvX id=b1slEAAAQBAJ&pg=RA2-PA124&img=1&zoom=3&hl=en&sig=ACfU3U2409I id=b1slEAAAQBAJ&pg=RA2-PA125&img=1&zoom=3&hl=en&sig=ACfU3U2-Zsl id=b1slEAAAQBAJ&pg=RA2-PA126&img=1&zoom=3&hl=en&sig=ACfU3U1ht3e id=b1slEAAAQBAJ&pg=RA2-PA127&img=1&zoom=3&hl=en&sig=ACfU3U2RK-J id=b1slEAAAQBAJ&pg=RA2-PA128&img=1&zoom=3&hl=en&sig=ACfU3U1G-7S id=b1slEAAAQBAJ&pg=RA2-PA129&img=1&zoom=3&hl=en&sig=ACfU3U2SWJj id=b1slEAAAQBAJ&pg=RA2-PA130&img=1&zoom=3&hl=en&sig=ACfU3U2JDld id=b1slEAAAQBAJ&pg=RA2-PA131&img=1&zoom=3&hl=en&sig=ACfU3U1hjKP id=b1slEAAAQBAJ&pg=RA2-PA132&img=1&zoom=3&hl=en&sig=ACfU3U0ty9L id=b1slEAAAQBAJ&pg=RA2-PA133&img=1&zoom=3&hl=en&sig=ACfU3U3oM2F id=b1slEAAAQBAJ&pg=RA2-PA134&img=1&zoom=3&hl=en&sig=ACfU3U1LD-C id=b1slEAAAQBAJ&pg=RA2-PA135&img=1&zoom=3&hl=en&sig=ACfU3U36EMS id=b1slEAAAQBAJ&pg=RA2-PA136&img=1&zoom=3&hl=en&sig=ACfU3U1AOCq id=b1slEAAAQBAJ&pg=RA2-PA137&img=1&zoom=3&hl=en&sig=ACfU3U034KR id=b1slEAAAQBAJ&pg=RA2-PA138&img=1&zoom=3&hl=en&sig=ACfU3U0fqEn id=b1slEAAAQBAJ&pg=RA2-PA139&img=1&zoom=3&hl=en&sig=ACfU3U22VEd id=b1slEAAAQBAJ&pg=RA2-PA140&img=1&zoom=3&hl=en&sig=ACfU3U2fisG id=b1slEAAAQBAJ&pg=RA2-PA141&img=1&zoom=3&hl=en&sig=ACfU3U1atRL id=b1slEAAAQBAJ&pg=RA2-PA142&img=1&zoom=3&hl=en&sig=ACfU3U1V55a id=b1slEAAAQBAJ&pg=RA2-PA143&img=1&zoom=3&hl=en&sig=ACfU3U0JrXN id=b1slEAAAQBAJ&pg=RA2-PA144&img=1&zoom=3&hl=en&sig=ACfU3U1sky7 id=b1slEAAAQBAJ&pg=RA2-PA145&img=1&zoom=3&hl=en&sig=ACfU3U0emIz id=b1slEAAAQBAJ&pg=RA2-PA146&img=1&zoom=3&hl=en&sig=ACfU3U2WKcP id=b1slEAAAQBAJ&pg=RA2-PA147&img=1&zoom=3&hl=en&sig=ACfU3U2O9AZ id=b1slEAAAQBAJ&pg=RA2-PA148&img=1&zoom=3&hl=en&sig=ACfU3U30yOB id=b1slEAAAQBAJ&pg=RA2-PA149&img=1&zoom=3&hl=en&sig=ACfU3U2GtZ8 id=b1slEAAAQBAJ&pg=RA2-PA150&img=1&zoom=3&hl=en&sig=ACfU3U2Pfhc id=b1slEAAAQBAJ&pg=RA2-PA151&img=1&zoom=3&hl=en&sig=ACfU3U1_ncN id=b1slEAAAQBAJ&pg=RA2-PA152&img=1&zoom=3&hl=en&sig=ACfU3U0AjxD id=b1slEAAAQBAJ&pg=RA2-PA153&img=1&zoom=3&hl=en&sig=ACfU3U3zyQU id=b1slEAAAQBAJ&pg=RA2-PA154&img=1&zoom=3&hl=en&sig=ACfU3U1De0b id=b1slEAAAQBAJ&pg=RA2-PA155&img=1&zoom=3&hl=en&sig=ACfU3U3pCYd id=b1slEAAAQBAJ&pg=RA2-PA156&img=1&zoom=3&hl=en&sig=ACfU3U0S8kN id=b1slEAAAQBAJ&pg=RA2-PA157&img=1&zoom=3&hl=en&sig=ACfU3U1mANm id=b1slEAAAQBAJ&pg=RA2-PA158&img=1&zoom=3&hl=en&sig=ACfU3U3xqDk id=b1slEAAAQBAJ&pg=RA2-PA159&img=1&zoom=3&hl=en&sig=ACfU3U344ZP id=b1slEAAAQBAJ&pg=RA2-PA160&img=1&zoom=3&hl=en&sig=ACfU3U0qVuF id=b1slEAAAQBAJ&pg=RA2-PA161&img=1&zoom=3&hl=en&sig=ACfU3U3RMuQ id=b1slEAAAQBAJ&pg=RA2-PA162&img=1&zoom=3&hl=en&sig=ACfU3U29cxf id=b1slEAAAQBAJ&pg=RA2-PA163&img=1&zoom=3&hl=en&sig=ACfU3U2ZxtK id=b1slEAAAQBAJ&pg=RA2-PA164&img=1&zoom=3&hl=en&sig=ACfU3U2frny id=b1slEAAAQBAJ&pg=RA2-PA165&img=1&zoom=3&hl=en&sig=ACfU3U3BZ5C id=b1slEAAAQBAJ&pg=RA2-PA166&img=1&zoom=3&hl=en&sig=ACfU3U0iv3P id=b1slEAAAQBAJ&pg=RA2-PA167&img=1&zoom=3&hl=en&sig=ACfU3U0gXYT id=b1slEAAAQBAJ&pg=RA2-PA168&img=1&zoom=3&hl=en&sig=ACfU3U1WnIy id=b1slEAAAQBAJ&pg=RA2-PA169&img=1&zoom=3&hl=en&sig=ACfU3U3foQH id=b1slEAAAQBAJ&pg=RA2-PA170&img=1&zoom=3&hl=en&sig=ACfU3U0IJzr id=b1slEAAAQBAJ&pg=RA2-PA171&img=1&zoom=3&hl=en&sig=ACfU3U2pEDa id=b1slEAAAQBAJ&pg=RA2-PA172&img=1&zoom=3&hl=en&sig=ACfU3U0FGiU id=b1slEAAAQBAJ&pg=RA2-PA173&img=1&zoom=3&hl=en&sig=ACfU3U38JHR id=b1slEAAAQBAJ&pg=RA2-PA174&img=1&zoom=3&hl=en&sig=ACfU3U0bVs2 id=b1slEAAAQBAJ&pg=RA2-PA175&img=1&zoom=3&hl=en&sig=ACfU3U3X9Y5 id=b1slEAAAQBAJ&pg=RA2-PA176&img=1&zoom=3&hl=en&sig=ACfU3U2n-k4 id=b1slEAAAQBAJ&pg=RA2-PA177&img=1&zoom=3&hl=en&sig=ACfU3U2KzXY index Z id=b1slEAAAQBAJ&pg=RA2-PA178&img=1&zoom=3&hl=en&sig=ACfU3U0kTNh id=b1slEAAAQBAJ&pg=RA2-PA179&img=1&zoom=3&hl=en&sig=ACfU3U1ktJ2 id=b1slEAAAQBAJ&pg=RA2-PA180&img=1&zoom=3&hl=en&sig=ACfU3U2b8-T id=b1slEAAAQBAJ&pg=RA2-PA181&img=1&zoom=3&hl=en&sig=ACfU3U1JR3r id=b1slEAAAQBAJ&pg=RA2-PA182&img=1&zoom=3&hl=en&sig=ACfU3U2UV4X id=b1slEAAAQBAJ&pg=RA2-PA183&img=1&zoom=3&hl=en&sig=ACfU3U1XhgM id=b1slEAAAQBAJ&pg=RA2-PA184&img=1&zoom=3&hl=en&sig=ACfU3U1ytZu id=b1slEAAAQBAJ&pg=RA2-PA185&img=1&zoom=3&hl=en&sig=ACfU3U29Pch id=b1slEAAAQBAJ&pg=RA2-PA186&img=1&zoom=3&hl=en&sig=ACfU3U2-fjD id=b1slEAAAQBAJ&pg=RA2-PA187&img=1&zoom=3&hl=en&sig=ACfU3U0xIPG id=b1slEAAAQBAJ&pg=RA2-PA188&img=1&zoom=3&hl=en&sig=ACfU3U3Z3i5 id=b1slEAAAQBAJ&pg=RA2-PA189&img=1&zoom=3&hl=en&sig=ACfU3U0nexh id=b1slEAAAQBAJ&pg=RA2-PA190&img=1&zoom=3&hl=en&sig=ACfU3U1sB7w id=b1slEAAAQBAJ&pg=RA2-PA191&img=1&zoom=3&hl=en&sig=ACfU3U2J1fe id=b1slEAAAQBAJ&pg=RA2-PA192&img=1&zoom=3&hl=en&sig=ACfU3U0mWUl id=b1slEAAAQBAJ&pg=RA2-PA193&img=1&zoom=3&hl=en&sig=ACfU3U2kf9P id=b1slEAAAQBAJ&pg=RA2-PA194&img=1&zoom=3&hl=en&sig=ACfU3U3DB50 id=b1slEAAAQBAJ&pg=RA2-PA195&img=1&zoom=3&hl=en&sig=ACfU3U1gArM id=b1slEAAAQBAJ&pg=RA2-PA196&img=1&zoom=3&hl=en&sig=ACfU3U38-L- id=b1slEAAAQBAJ&pg=RA2-PA197&img=1&zoom=3&hl=en&sig=ACfU3U2BptM id=b1slEAAAQBAJ&pg=RA2-PA198&img=1&zoom=3&hl=en&sig=ACfU3U1lqNz id=b1slEAAAQBAJ&pg=RA2-PA199&img=1&zoom=3&hl=en&sig=ACfU3U24RGT id=b1slEAAAQBAJ&pg=RA2-PA200&img=1&zoom=3&hl=en&sig=ACfU3U0bVPN id=b1slEAAAQBAJ&pg=RA2-PA201&img=1&zoom=3&hl=en&sig=ACfU3U3720K id=b1slEAAAQBAJ&pg=RA2-PA202&img=1&zoom=3&hl=en&sig=ACfU3U3qokz id=b1slEAAAQBAJ&pg=RA2-PA203&img=1&zoom=3&hl=en&sig=ACfU3U3M4Gb id=b1slEAAAQBAJ&pg=RA2-PA204&img=1&zoom=3&hl=en&sig=ACfU3U0-VWE id=b1slEAAAQBAJ&pg=RA2-PA205&img=1&zoom=3&hl=en&sig=ACfU3U2wZM7 id=b1slEAAAQBAJ&pg=RA2-PA206&img=1&zoom=3&hl=en&sig=ACfU3U0u569 id=b1slEAAAQBAJ&pg=RA2-PA207&img=1&zoom=3&hl=en&sig=ACfU3U0eclh id=b1slEAAAQBAJ&pg=RA2-PA208&img=1&zoom=3&hl=en&sig=ACfU3U2fAzn id=b1slEAAAQBAJ&pg=RA2-PA209&img=1&zoom=3&hl=en&sig=ACfU3U1bUnn id=b1slEAAAQBAJ&pg=RA2-PA210&img=1&zoom=3&hl=en&sig=ACfU3U3Cvtp id=b1slEAAAQBAJ&pg=RA2-PA211&img=1&zoom=3&hl=en&sig=ACfU3U0ANVz id=b1slEAAAQBAJ&pg=RA2-PA212&img=1&zoom=3&hl=en&sig=ACfU3U3IatD id=b1slEAAAQBAJ&pg=RA2-PA213&img=1&zoom=3&hl=en&sig=ACfU3U14UpL id=b1slEAAAQBAJ&pg=RA2-PA214&img=1&zoom=3&hl=en&sig=ACfU3U3mlgc id=b1slEAAAQBAJ&pg=RA2-PA215&img=1&zoom=3&hl=en&sig=ACfU3U0fN_h id=b1slEAAAQBAJ&pg=RA2-PA216&img=1&zoom=3&hl=en&sig=ACfU3U3R5Mt id=b1slEAAAQBAJ&pg=RA2-PA217&img=1&zoom=3&hl=en&sig=ACfU3U052Pp id=b1slEAAAQBAJ&pg=RA2-PA218&img=1&zoom=3&hl=en&sig=ACfU3U2H072 id=b1slEAAAQBAJ&pg=RA2-PA219&img=1&zoom=3&hl=en&sig=ACfU3U3MNPN id=b1slEAAAQBAJ&pg=RA2-PA220&img=1&zoom=3&hl=en&sig=ACfU3U1r3Sl id=b1slEAAAQBAJ&pg=RA2-PA221&img=1&zoom=3&hl=en&sig=ACfU3U342dU id=b1slEAAAQBAJ&pg=RA2-PA222&img=1&zoom=3&hl=en&sig=ACfU3U25yqS id=b1slEAAAQBAJ&pg=RA2-PA223&img=1&zoom=3&hl=en&sig=ACfU3U0kFBL id=b1slEAAAQBAJ&pg=RA2-PA224&img=1&zoom=3&hl=en&sig=ACfU3U3qo9g id=b1slEAAAQBAJ&pg=RA2-PA225&img=1&zoom=3&hl=en&sig=ACfU3U3kSHl id=b1slEAAAQBAJ&pg=RA2-PA226&img=1&zoom=3&hl=en&sig=ACfU3U14XJ_ id=b1slEAAAQBAJ&pg=RA2-PA227&img=1&zoom=3&hl=en&sig=ACfU3U182Jn id=b1slEAAAQBAJ&pg=RA2-PA228&img=1&zoom=3&hl=en&sig=ACfU3U1QgTI id=b1slEAAAQBAJ&pg=RA2-PA229&img=1&zoom=3&hl=en&sig=ACfU3U3KyF9 blank.pdf (p.2876) 04
